Compare AU
Compare JRHG vs. DRUG
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, shares and ETFs are a popular choice. Two options in the ASX are JRHG and DRUG. In this comparison, we'll delve into these options across various dimensions to help you make an informed investment decision.
Community Stats
JRHG | DRUG | |
|---|---|---|
Popularity | N/A | Low |
Pearlers invested | 0 | 61 |
Median incremental investment | $0 | $920.50 |
Median investment frequency | N/A | Monthly |
Median total investment | $0 | $1,892.10 |
Average age group | N/A | 26 - 35 |
Key Summary
JRHG | DRUG | |
|---|---|---|
Strategy | JRHG.AX was created on 2023-11-16 by JPMorgan. The fund's investment portfolio concentrates primarily on total market equity. | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. |
Top 3 holdings | Jpmorgan Gl Re En In Eqh Active ETF (Managed Fund) (100 %) | CHF - SWISS FRANC (0 %) AUD - AUSTRALIA DOLLAR (0 %) DKK - DANISH KRONE (0 %) |
Top 3 industries | Other (75.53 %) Communication Services (33.53 %) Health Care (24.47 %) | |
Top 3 countries | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) | |
Management fee | 0.3 % | 0.57 % |
Key Summary
JRHG | DRUG | |
|---|---|---|
Issuer | JPMorgan | BetaShares |
Tracking index | MSCI World ex Australia - AUD - Benchmark TR Net Hedged | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.3 % | 0.57 % |
Price | $63.91 | $7.95 |
Size | N/A | $185.172 million |
10Y return | N/A | N/A |
Annual dividend/ distribution yield (5Y) | 0.14 % | 1.90 % |
Market | ASX | ASX |
First listed date | 15/11/2023 | 08/08/2016 |
Purchase fee | $6.50 | $6.50 |
Community Stats
JRHG | DRUG | |
|---|---|---|
Popularity | N/A | Low |
Pearlers invested | 0 | 61 |
Median incremental investment | $0 | $920.50 |
Median investment frequency | N/A | Monthly |
Median total investment | $0 | $1,892.10 |
Average age group | N/A | 26 - 35 |
Pros and Cons
JRHG | DRUG | |
|---|---|---|
Pros |
|
|
Cons |
|
|
JRHG | DRUG |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Lower management fee | Higher management fee |
Lower price growth | Higher price growth |
Lower distribution yield | Higher distribution yield |